Loading cancer entity…
Loading cancer entity…
Clinical trials
805 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00965250 | Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy | completed | Phase 2 | 49 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2016 | clinicaltrials |
| NCT01374451 | Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET(COOPERATE-2) | terminated | Phase 2 | 160 | Novartis PharmaceuticalsINDUSTRY | 19 | Dec 20, 2016 |
| clinicaltrials |
| NCT02375464 | Gallium-68 DOTATOC for Management of Neuroendocrine Tumors | no longer available | — | — | Northwell HealthOTHER | 0 | Nov 8, 2016 | clinicaltrials |
| NCT02358018 | 68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial | no longer available | — | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 2, 2016 | clinicaltrials |
| NCT00804336 | Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors | completed | Phase 1 | 22 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 19, 2016 | clinicaltrials |
| NCT02078843 | Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors(GaIN) | terminated | Phase 1 / Phase 2 | 54 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Sep 7, 2016 | clinicaltrials |
| NCT01371643 | Surgical Debulking of Pituitary Adenomas | completed | Phase 4 | 41 | NYU Langone HealthOTHER | 1 | Aug 29, 2016 | clinicaltrials |
| NCT01620138 | Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas | completed | Phase 2 / Phase 3 | 21 | Universidade Federal do Rio de JaneiroOTHER | 1 | Aug 22, 2016 | clinicaltrials |
| NCT00580320 | Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma | completed | Phase 1 | 17 | Virginia Commonwealth UniversityOTHER | 1 | Aug 18, 2016 | clinicaltrials |
| NCT00869050 | Capecitabine and Temozolomide for Neuroendocrine Cancers | completed | Phase 2 | 41 | Columbia UniversityOTHER | 1 | Jul 25, 2016 | clinicaltrials |
| NCT01099228 | Combination Targeted Radiotherapy in Neuroendocrine Tumors | completed | N/A | 2 | David BushnellOTHER | 1 | Jul 21, 2016 | clinicaltrials |
| NCT01384617 | Trial Assessing Roux-en-Y Anastomosis of the Pancreatic Stump to Prevent Pancreatic Fistula Following Distal Pancreatectomy | completed | N/A | 136 | Wakayama Medical UniversityOTHER | 1 | Jul 21, 2016 | clinicaltrials |
| NCT02838862 | Identification of Biomarker Profiles GEP-NEN Patients | unknown | — | 470 | University Hospital Schleswig-HolsteinOTHER | 1 | Jul 20, 2016 | clinicaltrials |
| NCT01204476 | Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Jul 15, 2016 | clinicaltrials |
| NCT00049023 | Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors | completed | Phase 1 | 27 | O'Dorisio, M SOTHER | 1 | Jun 21, 2016 | clinicaltrials |
| NCT01048086 | 90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET) | withdrawn | Phase 2 | 0 | University of IowaOTHER | 1 | Jun 21, 2016 | clinicaltrials |
| NCT01155258 | Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | Jun 13, 2016 | clinicaltrials |
| NCT00416767 | Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery | completed | Phase 2 | 20 | Federation Francophone de Cancerologie DigestiveOTHER | 0 | May 30, 2016 | clinicaltrials |
| NCT01755182 | Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors(LOTUS) | terminated | Phase 3 | 1 | National Cancer Institute, NaplesOTHER | 1 | May 6, 2016 | clinicaltrials |
| NCT02759718 | Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors(CgA) | unknown | Phase 4 | 111 | Asan Medical CenterOTHER | 0 | May 3, 2016 | clinicaltrials |
| NCT01658436 | BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy. | completed | Phase 2 | 31 | Novartis PharmaceuticalsINDUSTRY | 9 | May 2, 2016 | clinicaltrials |
| NCT01628913 | Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors | terminated | Phase 2 | 62 | Novartis PharmaceuticalsINDUSTRY | 8 | Apr 7, 2016 | clinicaltrials |
| NCT01860742 | Randomized Phase III of PRRT Versus Interferon(CASTOR) | withdrawn | Phase 3 | 0 | Jules Bordet InstituteOTHER | 1 | Apr 5, 2016 | clinicaltrials |
| NCT01317615 | RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation | completed | Phase 4 | 49 | Novartis PharmaceuticalsINDUSTRY | 1 | Mar 30, 2016 | clinicaltrials |
| NCT02709863 | Comparison of The Effects of Sevoflurane, Desflurane and Total Intravenous Anaesthesia on Pulmonary Function Tests | unknown | N/A | 90 | Istanbul UniversityOTHER | 1 | Mar 16, 2016 | clinicaltrials |
| NCT02455596 | Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors | unknown | Phase 2 | 20 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Jan 5, 2016 | clinicaltrials |
| NCT01099540 | Study of Pazopanib Monotherapy in Patients With Unresectable, Metastatic Neuroendocrine Tumor | completed | Phase 2 | 37 | Samsung Medical CenterOTHER | 1 | Dec 29, 2015 | clinicaltrials |
| NCT02624154 | Pancreatic Neuroendocrine Tumor：Factor of Surgery Influencing Survival | unknown | — | 2 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 0 | Dec 8, 2015 | clinicaltrials |
| NCT00610129 | Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET) | completed | Phase 2 | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT01135849 | B-Receptor Signaling in Cardiomyopathy | completed | — | 99 | Daniel BernsteinOTHER | 1 | Nov 17, 2015 | clinicaltrials |
| NCT00227773 | Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors | withdrawn | Phase 2 | 0 | Eastern Cooperative Oncology GroupNETWORK | 0 | Oct 8, 2015 | clinicaltrials |
| NCT01548482 | Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Oct 6, 2015 | clinicaltrials |
| NCT00798057 | Proton Radiation Therapy for Pituitary Adenoma(PI01) | terminated | — | 16 | University of FloridaOTHER | 1 | Oct 5, 2015 | clinicaltrials |
| NCT00397384 | Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer | completed | Phase 1 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT02560376 | 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis | unknown | Early Phase 1 | 100 | Peking Union Medical College HospitalOTHER | 1 | Sep 25, 2015 | clinicaltrials |
| NCT02539433 | Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA) | completed | N/A | 22 | Northwell HealthOTHER | 1 | Sep 3, 2015 | clinicaltrials |
| NCT00978211 | DOTA-TOC in Metastasized Neuroendocrine Tumors | completed | Phase 2 | 1,499 | University Hospital, Basel, SwitzerlandOTHER | 1 | Aug 7, 2015 | clinicaltrials |
| NCT02125929 | Comparative Study of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neoplasms | completed | N/A | 156 | Peking Union Medical College HospitalOTHER | 1 | Aug 6, 2015 | clinicaltrials |
| NCT01775332 | Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools | unknown | N/A | 60 | Unity Health TorontoOTHER | 1 | Jul 31, 2015 | clinicaltrials |
| NCT01215578 | Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors(NET) | terminated | Phase 2 | 33 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00937079 | Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients | completed | — | 30 | University Hospital, Basel, SwitzerlandOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT01689064 | Comparison of Surgical Approach to Endoscopic Pituitary Adenoma Resection | completed | N/A | 55 | University of CalgaryOTHER | 1 | Dec 3, 2014 | clinicaltrials |
| NCT00412061 | Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor(RADIANT-2) | completed | Phase 3 | 429 | Novartis PharmaceuticalsINDUSTRY | 15 | Nov 21, 2014 | clinicaltrials |
| NCT00131911 | Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors | completed | Phase 2 | 93 | National Cancer Institute (NCI)NIH | 1 | Nov 17, 2014 | clinicaltrials |
| NCT01088763 | Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia | terminated | Phase 1 | 129 | National Cancer Institute (NCI)NIH | 2 | Nov 5, 2014 | clinicaltrials |
| NCT02279758 | A Pilot Study of Metformin Treatment in Patients With Well-differentiated Neuroendocrine Tumors(MetNet) | unknown | Phase 2 | 30 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Oct 31, 2014 | clinicaltrials |
| NCT02246322 | A Clinical Trial With a New Needle Device Comparing Two Needles for EUS_FNA of Solid Lesions.(EUS-FNA) | unknown | N/A | 144 | Istituto Clinico HumanitasOTHER | 1 | Sep 22, 2014 | clinicaltrials |
| NCT00002947 | Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer | terminated | Phase 1 | 35 | Yale UniversityOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT01121562 | Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors | completed | Phase 2 | 12 | PfizerINDUSTRY | 1 | Jun 30, 2014 | clinicaltrials |
| NCT01465672 | Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis | completed | — | 125 | University Hospital, Basel, SwitzerlandOTHER | 1 | May 20, 2014 | clinicaltrials |
Data updated 22 days agoSource updated Dec 23, 2016source: clinicaltrials